Zydus Cadila secures USFDA nod for Nortriptyline Hydrochloride Capsules Ruchika Sharma27 Feb 2021 10:00 AM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the USFDA to market Nortriptyline...
Zydus Cadila arm Sentynl buys Copper Histidinate product candidate from Cyprium Ruchika Sharma26 Feb 2021 12:00 PM ISTUnder the agreement, Cyprium is eligible to receive up to $20 million in upfront development and regulatory cash milestones through NDA approval, as...
Zydus Cadila secures USFDA nod for Droxidopa Capsules to treat low blood pressure Ruchika Sharma19 Feb 2021 1:05 PM ISTAhmedabad: Pharma major, Zydus Cadila, today announced that the company has received final approval from the USFDA to market Droxidopa Capsules, 100...
Zydus Cadila division settles patent litigation with Adamas Pharma over dyskinesia drug Gocovri Farhat Nasim17 Feb 2021 6:23 PM ISTNew Delhi: The US generic drug division of Zydus Cadila Healthcare, Zydus Pharmaceuticals (USA) Inc., and Zydus Worldwide DMCC recently entered into a...
Zydus Cadila net profit rises 41 percent to Rs 527 crore in Q3 Ruchika Sharma8 Feb 2021 10:00 AM ISTAhmedabad: Pharmaceutical major Zydus Cadila said on Friday its profit after tax was up by 41 per cent to Rs 527 crore in Q3 FY21 as compared to the...
Zydus Cadila completes patient enrolment for 2 Phase III trials of Desidustat Ruchika Sharma6 Feb 2021 10:00 AM ISTAhmedabad: Zydus Cadila, global pharmaceutical company, has recently announced that the company has completed patient enrolment in DREAM-ND and...
Zydus Cadila completes Phase-I trials of single dose cure for Malaria Ruchika Sharma5 Feb 2021 12:53 PM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company's antimalarial compound ZY19489 (MMV253) in development with Swiss-based...
Zydus Cadila gets USFDA Orphan Drug Designation for Saroglitazar Mg to treat PBC Ruchika Sharma29 Jan 2021 12:11 PM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
Zydus Cadila Desidustat shows efficacy, safety in treating Hypoxia in COVID-19 patients Ruchika Sharma26 Jan 2021 11:00 AM ISTAhmedabad: Drug major, Zydus Cadila, has recently announced that the company has received positive results from Phase 2(b) studies of Desidustat...
Zydus Cadila gets USFDA nod for Liothyronine Sodium Tablets to treat underactive thyroid Ruchika Sharma25 Jan 2021 11:36 AM ISTAhmedabad: Pharma major, Zydus Cadila, has recently announced that the company has received final approval from the United States Food &...
All Covid-19 vaccines to be stored at 2-8 degrees Celsius: Dept of Biotechnology Ruchika Sharma6 Jan 2021 1:10 PM ISTNew Delhi: All Indian vaccines being developed against the coronavirus can be stored at 2-8 degrees Celsius as the logistics have been worked out...
Zydus Cadila secures DCGI nod to start Phase III Clinical Trial of ZyCoV-D to prevent COVID Ruchika Sharma4 Jan 2021 12:28 PM ISTZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials.
